leadf
logo-loader
viewDeepVerge plc

Integumen's Gerry Brandon outlines collaboration with Avacta for real-time coronavirus detection

Integumen PLC's (LON:SKIN) Gerry Brandon caught up with Proactive London's Andrew Scott after announcing a collaboration with Avacta PLC (LON:AVCT) to use their technology in a coronavirus (COVID-19) detection kit. He says they've signed a material transfer agreement to use recently-generated affimers that bind the SARS-COV-2 spike protein to pick up the signs of the respiratory infection in wastewater.

Quick facts: DeepVerge plc

Price: 25.5 GBX

AIM:DVRG
Market: AIM
Market Cap: £28.95 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of DeepVerge plc named herein, including the promotion by the Company of DeepVerge plc in any Content on the Site, the Company receives from said...

FOR OUR FULL DISCLAIMER CLICK HERE

Integumen PLC to seek fast-track approval for its new coronavirus breath test

Integumen PLC's (LON:SKIN) Gerry Brandon speaks to Proactive's Andrew Scott after unveiling a new personalised coronavirus breath test, Microtox BT, and a complimentary digital health pass platform which he says has the potential to enable instant real-time testing for the virus. Brandon says...

3 weeks, 4 days ago

2 min read